Yingzhuo Xu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury.
Journal: Respiratory research
Published: November 26, 2022
Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma.
Journal: Cancer science
Published: November 10, 2022
NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer.
Journal: Cell death & disease
Published: February 24, 2022
Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer.
Journal: Cell death & disease
Published: January 20, 2022
Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer.
Journal: Journal for immunotherapy of cancer
Published: January 11, 2022
PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: November 11, 2021
REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis.
Journal: Cell death & disease
Published: September 23, 2021
Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors.
Journal: Cell death discovery
Published: August 01, 2021
BRD4-IRF1 axis regulates chemoradiotherapy-induced PD-L1 expression and immune evasion in non-small cell lung cancer.
Journal: Clinical and translational medicine
Published: July 17, 2021
CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer.
Journal: Journal of hematology & oncology
Published: October 10, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026